Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
04/2013
04/24/2013CN102579354B Hypericin albumin nanoparticle-immune globulin G antibody conjugate and preparation method thereof
04/24/2013CN102579350B Pidotimod liposome solid preparation
04/24/2013CN102525987B Diclofenac sodium slow-release tablet and preparation method thereof
04/24/2013CN102525926B Propylene glycol amine derivate cationic liposome nano particles and preparation method thereof
04/24/2013CN102462659B Citicoline sodium injection and preparation method thereof
04/24/2013CN102443186B Preparation method of epoxy chloropropane cross-linked chitosan microspheres
04/24/2013CN102406625B Buflomedil hydrochloride sustained release tablet with high release rate and preparation method thereof
04/24/2013CN102389571B Medicine sustained-release suppository used for in-vivo injection
04/24/2013CN102357074B Anti-tumor multi-medicine resistant targeted liposome
04/24/2013CN102319214B Lipid microsphere injection containing sodium demethyl cantharidate-phosphatide complex and preparation method thereof
04/24/2013CN102309721B Preparation method of black paste
04/24/2013CN102309464B Folic acid tablet and preparation method thereof
04/24/2013CN102309460B Pyridostigmine bromide odor masking orally disintegrating tablets and preparation method thereof
04/24/2013CN102309454B Preparation method of econazole nitrate/polyacrylic resin cationic nanoparticles
04/24/2013CN102258789B Miniaturized Endoglin antibody and adriamycin conjugate and preparation method thereof
04/24/2013CN102228424B Drug sustained-release system for treating tumours and preparation method thereof
04/24/2013CN102212198B Double-arm star polylactic acid-polydimethylaminoethyl methacrylate amphiphilic block copolymer and preparation method thereof
04/24/2013CN102212197B Hyperbranched star polylactic acid-polydimethylaminoethyl methacrylate amphiphilic block copolymer and preparation method thereof
04/24/2013CN102198274B Preparation method of raloxifene cyclodextrin inclusion compound and preparation of raloxifene cyclodextrin inclusion compound
04/24/2013CN102198084B Paclitaxel mixed micelle preparation, and preparation method thereof
04/24/2013CN102170855B Hyaluronic acid-based gels including anesthetic agents
04/24/2013CN102125699B Fe3O4/TiO2 composite nano-particles as well as preparation method and application thereof in magnetic resonance imaging contrast medium
04/24/2013CN102125533B Pazufloxacin mesylate tablet and preparation method and detection method thereof
04/24/2013CN102106828B Thymalfasin sustained-release microsphere preparation and preparation method thereof
04/24/2013CN102100904B Reduced glutathione percutaneous absorption preparation and preparation method thereof
04/24/2013CN102100677B Entecavir dispersible tablets and preparation method thereof
04/24/2013CN102100671B Method for preparing esomeprazole enteric capsules
04/24/2013CN102085185B Formula and preparation method of novel propofol fat emulsion preparation causing no pain and low injection stimulation
04/24/2013CN102078287B Ophthalmic gel of artificial musk and preparation method thereof
04/24/2013CN102031278B Method for enzymatic synthesis of trehalose unsaturated fatty acid diester in organic phase
04/24/2013CN102014962B Dissolvable nano web porous film and method of preparing the same
04/24/2013CN102008552B Daphniphyllum calycinum and Polygonum hydropiper Linn dispersible tablet for gastrointestinal health and preparation method thereof
04/24/2013CN101979093B Composition comprising polypeptide-drug substance and other poorly absorbed active ingredient and its use
04/24/2013CN101970011B Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
04/24/2013CN101909640B Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly
04/24/2013CN101879137B Method for preparing stealth liposome
04/24/2013CN101815535B Molecules for targeting compounds to various selected organs or tissues
04/24/2013CN101784287B Aqueous composition
04/24/2013CN101703764B Medicament for treating degenerative osteopathy and preparation method thereof
04/24/2013CN101686976B Stable solid preparation comprising 4,5-epoxymorphinan derivative
04/24/2013CN101668544B Preparation for transnasal application
04/24/2013CN101537015B Application of carbon nano-tubes in immunity accelerators for preparing anti-tumor immunotherapy medicaments
04/24/2013CN101522221B A process for manufacturing a delivery system for active components as part of an edible composition
04/24/2013CN101511390B Method for the production of conjugates of insulin-like growth factor-i and poly(ethylene glycol)
04/24/2013CN101190206B Orally-administered solid composition capable of reducing irritation of digestion tube
04/23/2013US8426571 Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer
04/23/2013US8426476 Biobeneficial coating compositions and methods of making and using thereof
04/23/2013US8426474 Antimicrobial wash and carrier solutions and uses thereof
04/23/2013US8426357 Multimeric conjugate
04/23/2013US8426205 Method for selective electrofusion of at least two fusion partners having cell-like membranes
04/23/2013US8426167 Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides
04/23/2013US8425935 Pharmaceutical formulation for producing rapidly disintegrating tablets
04/23/2013US8425930 Prebiotic oligosaccharides
04/23/2013US8425922 Adjuvant compositions and methods of use
04/23/2013US8425917 Mutant forms of EtxB and CtxB and their use as carriers
04/23/2013US8425912 Immunoconjugates with an intracellularly-cleavable linkage
04/23/2013US8425892 Extended, controlled-release pharmaceutical compositions using charged polymers
04/23/2013CA2752530C Delivery of active agents using a chocolate vehicle
04/23/2013CA2666322C Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof
04/23/2013CA2581125C Modified poly(ethylene oxide-amino acid) copolymer, micelle preparation, and anticancer agent containing the same
04/23/2013CA2580639C Stable dosing form of phenylalanine derivatives
04/23/2013CA2516331C Combination therapy using glycosaminoglycans and therapeutic agents for the treatment of respiratory disorders
04/23/2013CA2504818C Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
04/23/2013CA2497255C Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers
04/23/2013CA2475102C Stabilized synthetic immunogen delivery systems
04/23/2013CA2473212C Pharmaceutical composition which improves in vivo gene transfer
04/23/2013CA2458394C Lipophilic drug compositions
04/23/2013CA2377517C Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same
04/18/2013WO2013056213A1 Ingestible multi-sheet unit having predetermined functions and combinations
04/18/2013WO2013056170A1 In situ forming hydrogel and method using same
04/18/2013WO2013056132A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
04/18/2013WO2013056113A1 Nanocomposites of gold and polymers
04/18/2013WO2013056096A1 Polypeptide-opioid conjugates and uses thereof
04/18/2013WO2013055987A1 Pyrrolobenzodiazepines and conjugates thereof
04/18/2013WO2013055791A1 Polymeric nanoparticles for ultrasound imaging and therapy
04/18/2013WO2013055058A2 Antibody-binding peptide-ferritin fusion protein and uses thereof
04/18/2013WO2013055041A1 Emulsified hydrogel composition and a production method therefor
04/18/2013WO2013054872A1 TABLET INCLUDING 7-[4-(4-BENZO[b]THIOPHEN-4-YL-PIPERAZIN-1-YL) BUTOXY]-1H-QUINOLIN-2-ONE OR SALT THEREOF
04/18/2013WO2013054809A1 External preparation for skin
04/18/2013WO2013054330A1 Foam formulations
04/18/2013WO2013054123A1 Methods
04/18/2013WO2013054110A2 Compositions for binding to amyloid proteins
04/18/2013WO2013054063A1 Method for preparing complexes comprising amylose assembled with at least one organic molecule of interest
04/18/2013WO2013053856A1 Prevention and treatment of ocular conditions
04/18/2013WO2013053502A1 Method for cultivation of stem cells
04/18/2013WO2013053042A1 Porphyrin-phospholipid conjugate microbubbles and their use as contrast agents.
04/18/2013WO2013026913A3 Protein comprising nc-1 for treating angiogenesis-related diseases
04/18/2013WO2013006761A3 Pyrroloquinolinyl-pyrrolidine-2,5-dione formulations and methods for preparing and using same
04/18/2013WO2013006683A3 Bio-mimetic ultrathin hydrogel coatings for pancreatic islet transplantation
04/18/2013WO2012145491A3 Composition and method for enhancing an immune response
04/18/2013WO2012003349A3 Dissolvable fibrous web structure article comprising active agents
04/18/2013US20130096293 Cyclodextrin-based polymers for therapeutics delivery
04/18/2013US20130096210 Metal-organic frameworks with exceptionally large pore aperatures
04/18/2013US20130096209 Compounds, Compositions, And Methods For Reducing Or Eliminating Bitter Taste
04/18/2013US20130096205 Aqueous composition to be contained in container
04/18/2013US20130096203 Low toxicity topical active agent delivery system
04/18/2013US20130096202 Disinfecting and sterilising solutions
04/18/2013US20130096201 Pharmaceutical Compositions Comprising Paracetamol and Process for Preparing The Same
04/18/2013US20130096196 Pharmaceutical semi-solid composition of isotretinoin
04/18/2013US20130096194 Antimicrobial articles